1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Global Intramuscular Drug Delivery Industry 2015 Market Research Report


The Global Intramuscular Drug Delivery Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Intramuscular Drug Delivery industry.

The report provides a basic overview of the industry including definitions and classifications. The Intramuscular Drug Delivery market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

With 137 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Intramuscular Drug Delivery Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Basic Information of Intramuscular Drug Delivery
1.1.1 Definition of Intramuscular Drug Delivery
1.1.2 Classifications of Intramuscular Drug Delivery
1.1.3 Applications of Intramuscular Drug Delivery
1.1.4 Characteristics of Intramuscular Drug Delivery
1.2 Development Overview of Intramuscular Drug Delivery
1.3 Enter Barriers Analysis of Intramuscular Drug Delivery

2 Intramuscular Drug Delivery International and China Market Analysis
2.1 Intramuscular Drug Delivery Industry International Market Analysis
2.1.1 Intramuscular Drug Delivery International Market Development History
2.1.2 Intramuscular Drug Delivery Competitive Landscape Analysis
2.1.3 Intramuscular Drug Delivery International Main Countries Development Status
2.1.4 Intramuscular Drug Delivery International Market Development Trend
2.2 Intramuscular Drug Delivery Industry China Market Analysis
2.2.1 Intramuscular Drug Delivery China Market Development History
2.2.2 Intramuscular Drug Delivery Competitive Landscape Analysis
2.2.3 Intramuscular Drug Delivery China Main Regions Development Status
2.2.4 Intramuscular Drug Delivery China Market Development Trend
2.3 Intramuscular Drug Delivery International and China Market Comparison Analysis

3 Environment Analysis of Intramuscular Drug Delivery
3.1 International Economy Analysis
3.2 China Economy Analysis
3.3 Policy Analysis of Intramuscular Drug Delivery
3.4 News Analysis of Intramuscular Drug Delivery

4 Analysis of Revenue by Classifications
4.1 Global Revenue of Intramuscular Drug Delivery by Classifications 2010-2015
4.2 Global Revenue Growth Rate of Intramuscular Drug Delivery by Classifications 2010-2015
4.3 Intramuscular Drug Delivery Revenue by Classifications

5 Analysis of Revenue by Regions and Applications
5.1 Global Revenue of Intramuscular Drug Delivery by Regions 2010-2015
5.2 2010-2015 USA Revenue and Revenue Growth Rate of Intramuscular Drug Delivery
5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Intramuscular Drug Delivery
5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Intramuscular Drug Delivery
5.5 2010-2015 China Revenue and Revenue Growth Rate of Intramuscular Drug Delivery

6 Analysis of Intramuscular Drug Delivery Revenue Market Status 2010-2015
6.1 Revenue of Intramuscular Drug Delivery 2010-2015
6.2 Revenue Market Share Analysis of Intramuscular Drug Delivery 2010-2015
6.3 Revenue Overview of Intramuscular Drug Delivery 2010-2015
6.4 Gross Margin of Intramuscular Drug Delivery 2010-2015

7 Analysis of Intramuscular Drug Delivery Industry Key Manufacturers
7.1 Antares Pharma
7.1.1 Company Profile
7.1.2 Revenue and Gross Margin
7.1.3 Antares Pharma SWOT Analysis

7.2 Eli Lilly
7.2.1 Company Profile
7.2.2 Revenue and Gross Margin
7.2.3 Eli Lilly SWOT Analysis

7.3 GlaxoSmithKline
7.3.1 Company Profile
7.3.2 Revenue and Gross Margin
7.3.3 GlaxoSmithKline SWOT Analysis

7.4 Inovio Pharmaceuticals
7.4.1 Company Profile
7.4.2 Revenue and Gross Margin
7.4.3 Inovio Pharmaceuticals SWOT Analysis

7.5 Merck and Co.
7.5.1 Company Profile
7.5.2 Revenue and Gross Margin
7.5.3 Merck and Co. SWOT Analysis

7.6 Novartis
7.6.1 Company Profile
7.6.2 Revenue and Gross Margin
7.6.3 Novartis SWOT Analysis

7.7 Pacira Pharmaceuticals
7.7.1 Company Profile
7.7.2 Revenue and Gross Margin
7.7.3 Pacira Pharmaceuticals SWOT Analysis

7.8 Pfizer
7.8.1 Company Profile
7.8.2 Revenue and Gross Margin
7.8.3 Pfizer SWOT Analysis

7.9 Pharmajet
7.9.1 Company Profile
7.9.2 Revenue and Gross Margin
7.9.3 Pharmajet SWOT Analysis

7.10 Teva Pharmaceutical
7.10.1 Company Profile
7.10.2 Revenue and Gross Margin
7.10.3 Teva Pharmaceutical SWOT Analysis

8 Sales Price and Gross Margin Analysis
8.1 Sales Price Analysis of Intramuscular Drug Delivery
8.2 Gross Margin Analysis of Intramuscular Drug Delivery

9 Marketing Trader or Distributor Analysis of Intramuscular Drug Delivery
9.1 Marketing Channels Status of Intramuscular Drug Delivery
9.2 How Countries Meet Their Needs
9.2.1 USA
9.2.2 China
9.2.3 Japan
9.2.4 Germany

10 Development Trend of Intramuscular Drug Delivery Industry 2016-2021
10.1 Revenue Overview of Intramuscular Drug Delivery 2016-2021
10.2 Sales Price Overview of Intramuscular Drug Delivery 2016-2021

11 Industry Chain Suppliers of Intramuscular Drug Delivery with Contact Information
11.1 Equipment Suppliers of Intramuscular Drug Delivery with Contact Information
11.2 Major Suppliers of Intramuscular Drug Delivery with Contact Information
11.3 Key Consumers of Intramuscular Drug Delivery with Contact Information
11.4 Supply Chain Relationship Analysis of Intramuscular Drug Delivery

12 New Project Investment Feasibility Analysis of Intramuscular Drug Delivery
12.1 New Project SWOT Analysis of Intramuscular Drug Delivery
12.2 New Project Investment Feasibility Analysis of Intramuscular Drug Delivery

13 Conclusion of the Global Intramuscular Drug Delivery Industry 2015 Market Research Report



List of Tables and Figures
Table Classifications of Intramuscular Drug Delivery
Table Applications of Intramuscular Drug Delivery
Table Policy of Intramuscular Drug Delivery
Table Industry News List of Intramuscular Drug Delivery
Table Global Revenue of Intramuscular Drug Delivery by Classifications 2010-2015 (M USD)
Table Global Revenue Market Share of Intramuscular Drug Delivery by Classifications 2010-2015
Figure Global Revenue Market Share of Intramuscular Drug Delivery by Classifications in 2010
Figure Global Revenue Market Share of Intramuscular Drug Delivery by Classifications in 2015
Figure Global Revenue Growth Rate of Type One 2010-2015
Figure Global Revenue Growth Rate of Type Two 2010-2015
Figure Global Revenue Growth Rate of Type Three 2010-2015
Table USA Intramuscular Drug Delivery Revenue by Classifications
Table Europe Intramuscular Drug Delivery Revenue by Classifications
Table Japan Intramuscular Drug Delivery Revenue by Classifications
Table China Intramuscular Drug Delivery Revenue by Classifications
Table Global Revenue of Intramuscular Drug Delivery by Regions 2010-2015 (M USD)
Table Global Revenue Market Share of Intramuscular Drug Delivery by Regions 2010-2015
Figure Global Revenue Market Share of Intramuscular Drug Delivery by Regions in 2010
Figure Global Revenue Market Share of Intramuscular Drug Delivery by Regions in 2015
Table USA Intramuscular Drug Delivery Revenue by Applications
Figure USA Intramuscular Drug Delivery Revenue and Revenue Growth Rate
Table Europe Intramuscular Drug Delivery Revenue by Applications
Figure Europe Intramuscular Drug Delivery Revenue and Revenue Growth Rate
Table Japan Intramuscular Drug Delivery Revenue by Applications
Figure Japan Intramuscular Drug Delivery Revenue and Revenue Growth Rate
Table China Intramuscular Drug Delivery Revenue by Applications
Figure China Intramuscular Drug Delivery Revenue and Revenue Growth Rate
Table Global and China Major Players Intramuscular Drug Delivery Revenue of 2010-2015 (M USD)
Table Global and China Major Players Intramuscular Drug Delivery Revenue Market Share of 2010-2015
Table China Major Players Intramuscular Drug Delivery Revenue of 2010-2015 (M USD)
Table China Major Players Intramuscular Drug Delivery Revenue Market Share of 2010-2015
Figure Global Revenue Market Share of Major Intramuscular Drug Delivery Players in 2010
Figure Global Revenue Market Share of Major Intramuscular Drug Delivery Players in 2015
Figure China Revenue Market Share Major Intramuscular Drug Delivery Players in 2010
Figure China Revenue Market Share Major Intramuscular Drug Delivery Players in 2015
Figure Global Revenue and Growth Rate of Intramuscular Drug Delivery 2010-2015
Figure China Revenue and Growth Rate of Intramuscular Drug Delivery 2010-2015
Figure 2010-2015 Global and China Intramuscular Drug Delivery Revenue Comparison
Table Cost of Global Intramuscular Drug Delivery Major Players 2010-2015 (M USD)
Table Gross of Global Intramuscular Drug Delivery Major Players 2010-2015 (M USD)
Table Gross Margin of Global Intramuscular Drug Delivery Major Players 2010-2015
Figure Gross Margin of Global Intramuscular Drug Delivery Major Players in 2014
Table Company Profile List of Antares Pharma
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Antares Pharma 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Antares Pharma 2010-2015
Table SWOT Analysis of Antares Pharma 2010-2015
Table Company Profile List of Eli Lilly
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Eli Lilly 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Eli Lilly 2010-2015
Table SWOT Analysis of Eli Lilly 2010-2015
Table Company Profile List of GlaxoSmithKline
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of GlaxoSmithKline 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of GlaxoSmithKline 2010-2015
Table SWOT Analysis of GlaxoSmithKline 2010-2015
Table Company Profile List of Inovio Pharmaceuticals
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Inovio Pharmaceuticals 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Inovio Pharmaceuticals 2010-2015
Table SWOT Analysis of Inovio Pharmaceuticals 2010-2015
Table Company Profile List of Merck and Co.
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Merck and Co. 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Merck and Co. 2010-2015
Table SWOT Analysis of Merck and Co. 2010-2015
Table Company Profile List of Novartis
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Novartis 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Novartis 2010-2015
Table SWOT Analysis of Novartis 2010-2015
Table Company Profile List of Pacira Pharmaceuticals
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Pacira Pharmaceuticals 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Pacira Pharmaceuticals 2010-2015
Table SWOT Analysis of Pacira Pharmaceuticals 2010-2015
Table Company Profile List of Pfizer
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Pfizer 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Pfizer 2010-2015
Table SWOT Analysis of Pfizer 2010-2015
Table Company Profile List of Pharmajet
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Pharmajet 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Pharmajet 2010-2015
Table SWOT Analysis of Pharmajet 2010-2015
Table Company Profile List of Teva Pharmaceutical
Table Intramuscular Drug Delivery Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Teva Pharmaceutical 2010-2015
Figure Intramuscular Drug Delivery Revenue and Growth Rate of Teva Pharmaceutical 2010-2015
Table SWOT Analysis of Teva Pharmaceutical 2010-2015
Figure Intramuscular Drug Delivery Manufactor Profit Model
Figure Marketing Channels Status of Intramuscular Drug Delivery
Figure Global Revenue and Growth Rate of Intramuscular Drug Delivery 2016-2021
Figure China Revenue and Growth Rate of Intramuscular Drug Delivery 2016-2021
Figure Global and China Intramuscular Drug Delivery Revenue Comparison 2016-2021
Table Equipment Suppliers of Intramuscular Drug Delivery with Contact Information
Table Major Suppliers of Intramuscular Drug Delivery with Contact Information
Table Key Consumers of Intramuscular Drug Delivery with Contact Information
Figure Supply Chain Relationship Analysis of Intramuscular Drug Delivery
Table New Project SWOT Analysis of Intramuscular Drug Delivery


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520.0 billion in 2016, at a CAGR of 6.5% during the forecast period. Major factors contributing ...

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

  • $ 4995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence ...

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.